Marucci, M. A., Lechner , D. W., & Tafuto , B. A. (2024). Safety outcomes of low versus high dose imatinib mesylate in patients with advanced, metastatic, or nonresectable gastrointestinal stromal tumors: A systematic review. Gastrointestinal Tract, 2(1). https://doi.org/10.54844/git.2023.482